JOANBALONE

I agree with Malclom (as usual)

I agree with tskridge. We use temperature indicators on blood that is kept in remote storage (OR, SICU). I consider a Safe-T-Vue for "blood bank only" use.

Why do you keep 2 in the blood bank? JB

We have stopped this practice a few years ago with out any issues. JB

I agree with EDibble

CAP TRM41475 For patients receiving transfusions that will not be observed by medical personnel post-transfusion, instructions are provided to the patient regarding adverse reactions to transfusion.

I am all for 'no armbands' but if you must use them you can make an exception to your policy for the outpatients - they can take them home in an envelope and bring them back on day of surgery.

I agree with David.

Hi David, This is what I found from the FDA - 606.151 Compatibility testing. © Procedures to demonstrate incompatibility between the donor’s cell type and the recipient’s serum or plasma type. I cannot find the FDA requirement for ISXM. Can you post it?

How do you get blood to the patient care area in an emergency?

Me too.

I may not consider the mixed field pan agglutinin as junk. I would consider it an autoantibody most probably due to autoimmune disease. I would report an eluate positive with all cells. You mentioned that the antibody screen is negative so I would not perform additional testing. I agree with Malcolm, in terms of transfusion it is not considered clinically significant.

Has anyone been cited for not doing an immediate spin crossmatch in addition to a gel crossmatch and they have a validated computer system that detects ABO incompatibility?

Hi everyone, A few years ago many Transfusion Services started performing an immediate spin crossmatch in addition to IgG gel crossmatch even though the Transfusion Service had a validated computer system to detect ABO incompatibility. Is anyone not doing an immediate spin crossmatch in addition to IgG gel crossmatch when the patient has a clinically significant antibody (or history of) when you have a validated computer system to detect ABO incompatibility? If so, why not? has an inspector had a problem with this? what have you based your decision (CAP, AABB)? thanks for your input JB

It is a CAP requirement for sure. I am wondering what people consider "date in use"? JB

We are performing direct observation audits routinely so we are "QC'ing the user" to determine if the staff are performing the test correctly. We perform correlation studies 2 x year in which we correlate automated vs manual methods. I have searched the regulations and can't find any requirement addressing the initial post.

No. JB

I would suggest some sort of temperature indicator placed on each unit to determine if the unit was removed from the cooler and then returned to it. JB

We use gel method and most of our reagents are QC'd on the ProVue. We do not repeat the reagent QC using manual methods. The "manual" equipment, MTS centrifuge and incubator, are QC'd daily - temp - timer countdown, and displayed RPMs within certain range. JB

Our blood center charges about $150 for complete genotype. What are others being charged? JB

Is it possible to send the sample for genotype?

Dump the labels. This is the 21st century.

Hi jgabbard, How do you keep track of "dates in use/finish"? JB

Mabel, I completely understand.

I agree with Mabel JB